[go: up one dir, main page]

AU9689398A - Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer - Google Patents

Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Info

Publication number
AU9689398A
AU9689398A AU96893/98A AU9689398A AU9689398A AU 9689398 A AU9689398 A AU 9689398A AU 96893/98 A AU96893/98 A AU 96893/98A AU 9689398 A AU9689398 A AU 9689398A AU 9689398 A AU9689398 A AU 9689398A
Authority
AU
Australia
Prior art keywords
immunodiagnosis
immunotherapy
compounds
methods
prostate cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU96893/98A
Inventor
Davin C. Dillon
Jennifer L. Mitcham
Steven G. Reed
Daniel R. Twardzik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/946,026 external-priority patent/US6034218A/en
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU9689398A publication Critical patent/AU9689398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU96893/98A 1997-10-07 1998-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer Abandoned AU9689398A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08946026 1997-10-07
US08/946,026 US6034218A (en) 1996-03-15 1997-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
US10267998A 1998-06-23 1998-06-23
US09102679 1998-06-23
PCT/US1998/021166 WO1999018210A2 (en) 1997-10-07 1998-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Publications (1)

Publication Number Publication Date
AU9689398A true AU9689398A (en) 1999-04-27

Family

ID=26799614

Family Applications (1)

Application Number Title Priority Date Filing Date
AU96893/98A Abandoned AU9689398A (en) 1997-10-07 1998-10-07 Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer

Country Status (2)

Country Link
AU (1) AU9689398A (en)
WO (1) WO1999018210A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1343912A2 (en) 2000-11-28 2003-09-17 Wyeth Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
JP2004526425A (en) 2000-11-28 2004-09-02 ワイス Expression analysis of FKBP nucleic acids and polypeptides useful for diagnosis and treatment of prostate cancer
US20050085627A1 (en) 2001-06-21 2005-04-21 Youming Zhang Atopy
EP2320235A1 (en) * 2009-11-06 2011-05-11 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Marker for prostate cancer diagnosis
EP2320234A1 (en) 2009-11-06 2011-05-11 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Marker combination for prostate cancer diagnosis
EP2700949A1 (en) 2012-08-24 2014-02-26 IMG Institut für medizinische Genomforschung Planungsgesellschaft M.B.H. Use of biliverdin reductase proteins as cancer marker
BR112019020414A2 (en) * 2017-03-30 2020-06-09 Progastrine Et Cancers S.À R.L. compositions and methods to detect and treat prostate cancer using progastrin-binding molecules
JP2020535114A (en) * 2017-08-11 2020-12-03 トリビオティカ・エルエルシー How to generate an epitope that binds to a recognition molecule by a templated assembly
CN111679074A (en) * 2020-07-11 2020-09-18 成都益安博生物技术有限公司 A kind of peripheral blood TCR marker of prostate cancer and its detection kit and application

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4600637A1 (en) * 1996-03-15 1998-05-08 Corixa Corp COMPOUNDS FOR IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF CANCER OF PROSTATE

Also Published As

Publication number Publication date
WO1999018210A2 (en) 1999-04-15
WO1999018210A3 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
HUP0002095A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
IL131539A0 (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
NO984229D0 (en) Compounds and Methods for Immunotherapy and Immunodiagnosis of Prostate Cancer
AU2010699A (en) Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
AU6958498A (en) Method for detection of recurrent prostate cancer
AU1958897A (en) Egf-genistein conjugates for the treatment of cancer
AU6949498A (en) Method for assessing prostate cancer
AU2387900A (en) Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
AU3154297A (en) Materials and methods for detection of breast cancer
AU6468998A (en) Compositions and method for the early diagnosis of ovarian cancer
AU7012496A (en) Compounds and methods for treatment and diagnosis of prostate cancer
AU2292495A (en) Method for molecular staging of prostate cancer
AU5005697A (en) Methods of preventing breast cancer
AU8259798A (en) Method for detection of breast cancer
AU9689398A (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
AU9018598A (en) Prognostic compositions for prostate cancer and methods of use thereof
AU5369498A (en) Compounds and methods for treating cancer
AU7832700A (en) Ovarian tumor antigen and methods of use therefor
HK1019755A (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer
AU3370095A (en) Methods of inhibiting endometrial cancer
HK1024509A (en) Compounds for immunotherapy of prostate cancer and methods for their use
ZA981585B (en) Compounds for immunotherapy of prostate cancer and methods for their use
AU6536898A (en) Compounds for immunodiagnosis of prostate cancer and methods for their use
AU4417996A (en) Treatment of prostate cancer
ZA972238B (en) Compounds and methods for immunotherapy and immunodiagnosis of prostate cancer.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase